Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to Affordable Pricing Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Monday reacting to preliminary data released by Pfizer Inc. on the efficacy of the company’s COVID-19 vaccine. “Any COVID-19 treatments and vaccines that ultimately come to market must be priced […]
Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering Rx Prices and Reject Big Pharma Blame Game in Town Hall Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday ahead of a drug pricing town hall with representatives from both the Trump and Biden campaigns hosted by Patients for […]
Brand Name Drug Company Shirks Requirement to Provide Affordable Medications to Covered Providers as Industry Complains About High Discounts Partially Driven by Its Own Price Hikes Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday criticizing AstraZeneca for becoming the second Big Pharma giant to brazenly stop recognizing legally mandated prescription drug discounts […]
House Committee on Oversight and Reform to Question Big Pharma Executives During Two-Day Hearing on “Unsustainable Drug Prices” Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday ahead of two days of testimony from Big Pharma executives before the U.S. House Committee on Oversight and Reform on “Unsustainable Drug Prices.” […]
Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold Drug Companies Accountable Would Lower Prices And Increase Innovation Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a new study from Avik Roy and Gregg Girvan of the Foundation for Research on Equal Opportunity (FREOPP) which finds […]
Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Drug Prices, While Increasing Medicare Premiums Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Sunday in response to tweet chain from the president announcing he signed an executive order tying drug prices to those paid in other countries and pointing […]
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of Blockbuster Cancer, Immunosuppressant Drugs Will Help Hold Industry Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to news that the U.S. House Oversight Committee will subpoena Big Pharma giant AbbVie to obtain documents related to […]
Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name Drugs This Summer Despite Economic Crisis and Rising Concern With Rx Affordability Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on updated data showing Big Pharma continued hiking prescription drug prices through the summer while Americans […]
White House Should Reject Pharma-Backed Policies That Would Hand Drug Companies a Windfall on the Backs of American Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday in response to two alternative drug pricing proposals to Medicare Parts B and D presented by Big Pharma to the Trump administration […]
Encourages Administration to Reject Measure That Would Increase Premiums on Medicare Part D Beneficiaries, Cost Taxpayers Billions and Boost Profits for Drug Companies Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched a television and digital advertising campaign Tuesday against the proposed Rebate Rule in Washington, D.C. and eight key U.S. Senate and […]